Cargando…
Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
Autores principales: | Constantine, Andrew, Tulloh, Robert, Condliffe, Robin, Clift, Paul, Dimopoulos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822195/ https://www.ncbi.nlm.nih.gov/pubmed/31695906 http://dx.doi.org/10.1177/2045894019882627 |
Ejemplares similares
-
Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion
por: Constantine, Andrew, et al.
Publicado: (2021) -
Compliance with Driver and Vehicle Licensing Agency guidance in a psychiatric inpatient setting
por: Babu-Mathew, Nishanth, et al.
Publicado: (2021) -
Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease
por: Condliffe, R., et al.
Publicado: (2018) -
Driving Risk Assessment and Advice Provision for Inpatients Based on Features of Illness, Treatment and Driver and Vehicle Licensing Agency (DVLA) Guidelines
por: Ofovwe, Oghenefejiro, et al.
Publicado: (2022) -
Child/Adolescent development and autonomous vehicle operation: “operator’s licenses” instead of driver’s licenses
por: Schwebel, David C
Publicado: (2018)